Q6NZL8 (SCUB1_MOUSE) Mus musculus (Mouse)
Signal peptide, CUB and EGF-like domain-containing protein 1 UniProtKBInterProSTRINGInteractive Modelling
1018 aa; Sequence (Fasta) ; (Isoform 2; Isoform 3; )
It is possible new templates exist for this target since these models were created.
Sequence Features
| 37-50 | |||
| 44-59 | |||
| 61-72 | |||
| 78-91 | |||
| 87-100 | |||
| 102-115 | |||
| 121-132 | |||
| 128-141 | |||
| 316-327 | |||
| 323-336 | |||
| 338-351 | |||
| 357-367 | |||
| 363-376 | |||
| 378-390 | |||
| 396-407 | |||
| 403-416 | |||
| 828-854 | |||
| 881-902 | |||
| 37-72 | EGF domain IPR024731PF12947 | ||
| 98-120 | Complement Clr-like EGF domain IPR026823PF12662 | ||
| 353-387 | EGF-like calcium-binding domain IPR001881PF07645 | ||
| 392-428 | EGF-like calcium-binding domain IPR001881PF07645 | ||
| 666-713 | Tyrosine-protein kinase ephrin type A/B receptor-like IPR011641PF07699 | ||
| 720-767 | Tyrosine-protein kinase ephrin type A/B receptor-like IPR011641PF07699 | ||
| 776-823 | Tyrosine-protein kinase ephrin type A/B receptor-like IPR011641PF07699 | ||
| 828-937 | CUB domain IPR000859PF00431 |
Sequence Alignments
Homology models
| Oligo-state | QMEAN | Template | Range | Seq id (%) | Ligands |
|---|---|---|---|---|---|
| monomer | -3.83 | 2w86.1.A | 37.50 | ||
| Assess | |||||
| monomer | -2.31 | 5uk5.1.A | 29.03 | ||
| Assess | |||||
| monomer | -4.61 | 6b08.1.C | 21.92 | ||
| Assess | |||||
| monomer | -4.02 | 6pog.1.B | 36.62 | ||
| Assess | |||||
| monomer | -3.95 | 6pog.1.B | 33.59 | ||
| Assess | |||||
| monomer | -4.95 | 5uk5.1.B | 21.94 | ||
| Assess | |||||
Homology models built on isoform sequence
| Isoform | Oligo-state | Ligands | QMEAN | Template | Range | Seq id (%) |
|---|---|---|---|---|---|---|
| Isoform 2 | monomer | -3.86 | 2w86.1.A | 37.50 | ||
| Assess | ||||||
| Isoform 2 | monomer | -3.22 | 4yn0.1.A | 24.22 | ||
| Assess | ||||||
| Isoform 2 | monomer | -2.54 | 1uzj.2.A | 31.09 | ||
| Assess | ||||||
| Isoform 2 | monomer | -4.05 | 5fma.1.A | 32.14 | ||
| Assess | ||||||
| Isoform 2 | monomer | -2.40 | 5uk5.1.A | 29.27 | ||
| Assess | ||||||
| Isoform 2 | monomer | -4.94 | 4xbm.2.A | 24.90 | ||
| Assess | ||||||
| Isoform 2 | monomer | -4.51 | 1z1y.1.B | 26.12 | ||
| Assess | ||||||
| Isoform 2 | monomer | -4.10 | 6pog.1.B | 33.59 | ||
| Assess | ||||||
| Isoform 2 | monomer | -4.60 | 5uk5.1.B | 22.37 | ||
| Assess | ||||||
| Isoform 3 | monomer | -3.19 | 2qqk.2.A | 28.46 | ||
| Assess | ||||||
| Isoform 3 | monomer | -3.39 | 2qqo.1.A | 25.19 | ||
| Assess | ||||||
| Isoform 3 | monomer | -3.79 | 2w86.1.A | 37.50 | ||
| Assess | ||||||
| Isoform 3 | monomer | -3.35 | 4yn0.1.A | 24.22 | ||
| Assess | ||||||
| Isoform 3 | monomer | -4.88 | 6pog.1.B | 38.97 | ||
| Assess | ||||||
| Isoform 3 | monomer | -3.88 | 5fma.1.A | 32.14 | ||
| Assess | ||||||
| Isoform 3 | monomer | -4.67 | 4xbm.2.A | 24.50 | ||
| Assess | ||||||
| Isoform 3 | monomer | -2.27 | 5uk5.1.A | 29.27 | ||
| Assess | ||||||
| Isoform 3 | monomer | -3.97 | 6pog.1.B | 33.59 | ||
| Assess | ||||||